Dr Roy C Grekin, MD | |
2320 Bath Street, Suite 205, Santa Barbara, CA 93105-4339 | |
(805) 569-1164 | |
(805) 569-1094 |
Full Name | Dr Roy C Grekin |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 47 Years |
Location | 2320 Bath Street, Santa Barbara, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245278506 | NPI | - | NPPES |
00G510120 | Medicaid | CA | |
CQ929V | Other | CA | MEDICARE PTAN |
G510120 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | G51012 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ucsf Medical Center | San francisco, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of California San Francisco | 4486567229 | 1298 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies.
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson's disease, and even death.
› Verified 5 days ago
Entity Name | University Of California San Francisco |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies.
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson's disease, and even death.
› Verified 5 days ago
Entity Name | Ucsf Medical Group Business Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies.
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson's disease, and even death.
› Verified 5 days ago
Entity Name | University Of California Sfgh Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164497285 PECOS PAC ID: 5496668410 Enrollment ID: O20041015000522 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies.
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson's disease, and even death.
› Verified 5 days ago
Entity Name | City & County Of San Francisco |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982737524 PECOS PAC ID: 1658280748 Enrollment ID: O20050309000770 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies.
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson's disease, and even death.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Roy C Grekin, MD Po Box 50706, Santa Barbara, CA 93150-0706 Ph: (805) 963-3757 | Dr Roy C Grekin, MD 2320 Bath Street, Suite 205, Santa Barbara, CA 93105-4339 Ph: (805) 569-1164 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies.
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson's disease, and even death.
› Verified 5 days ago
Dr. Rebecca Dawn Miller, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 334 S Patterson Ave, Ste 105, Santa Barbara, CA 93111 Phone: 805-964-1514 Fax: 805-964-0861 | |
George Keith Llewellyn, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1722 State St, Ste 103, Santa Barbara, CA 93101 Phone: 805-884-4900 Fax: 805-884-4900 | |
Meredith A Perrin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 334 S Patterson Ave Ste 105, Santa Barbara, CA 93111 Phone: 805-964-1514 Fax: 805-964-0861 | |
Dr. Mark E Burnett, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2323 Oak Park Ln Ste 202, Santa Barbara, CA 93105 Phone: 805-892-8111 | |
Dr. Peter Ford, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-681-1761 Fax: 805-681-1768 | |
Dr. Thomas A Vanmeter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 334 S Patterson Ave, Ste 105, Santa Barbara, CA 93111 Phone: 805-964-1514 Fax: 805-964-0861 |